510(k) for Minntech's hemoconcentrator:
This article was originally published in Clinica
The FDA has cleared Minntech's Hemocor HPH 700 hemoconcentrator for use during open-heart surgery. The device removes excess fluid in the blood stream while retaining, or concentrating, the patient's red blood cells to minimise the need for donor blood. Due to its "no-rinse" technology, the product can be inserted into the bypass circuit at any time during the surgical procedure, the Minneapolis-based company said.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.